[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Diagnostics & Diseases Market Research Reports & Industry Analysis

Diagnostics involves investigating and discovering certain diseases, conditions and injuries by closely studying various symptoms and indications displayed by patients. In broad terms, today’s Diagnostics Industry breaks down into the following categories, namely in-vitro diagnostics (IVD) (examination of diverse tissue samples in a laboratory) and in-vivo diagnostics (observation and testing of tissue and any organ’s functioning by exploiting the techniques like medical (diagnostic) imaging and monitoring).

A nearly EUR 37.5 billion sector, in-vitro diagnostics promises enormous growth potential, with governments increasingly redefining soaring healthcare spending and starting to pour investments into the high tech diagnostics business. The latter continues to be superintended by a mere scattering of behemoths. Major forces fuelling the industry development include, among others, innovative approaches regarding equipment and clinical trial activities.

This Catalogue presents an invaluable collection of research reports examining the Diagnostics and Diseases Market worldwide, by various regions and selected countries. The research reports feature market sizing analyses and growth rate reviews, discussions of factors diving or deterring the growth of the Diagnostics and Diseases Industry, information on market dynamics and share, etc. The profiles of large-to-micro caps, and the Diagnostics and Diseases Market forecasts are provided in the research reports too.

Publications found: 43,318
Sort by:

New Frontiers in the Japanese Automated Microbiology Market: Business Challenges, Emerging Technologies, Competitive Landscape

US$ 7,080.00

Complete report $8,850. DataPack (test volumes, sales forecasts, supplier shares) $5,700. New Frontiers in the Japanese Automated Microbiology Market: Business Challenges, Emerging Technologies, Competitive Land scape is Venture Planning Group’s new analysis of the major business opportunities emerging ...

May 2014 421 pages

New Frontiers in the Spanish Automated Microbiology Market: Business Challenges, Emerging Technologies, Competitive Landscape

US$ 5,560.00

Complete report $6,950. DataPack (test volumes, sales forecasts, supplier shares) $4,500. New Frontiers in theSpanish Automated Microbiology Markets: Business Challenges, Emerging Technologies, Competitive Land scape is Venture Planning Group’s new analysis of the major business opportunities emerging ...

May 2014 417 pages

New Frontiers in the UK Automated Microbiology Market: Business Challenges, Emerging Technologies, Competitive Landscape

US$ 5,560.00

Complete report $6,950. DataPack (test volumes, sales forecasts, supplier shares) $4,500. New Frontiers in theUK Automated Microbiology Markets: Business Challenges, Emerging Technologies, Competitive Land scape is Venture Planning Group’s new analysis of the major business opportunities emerging in ...

May 2014 415 pages

New Frontiers in the US Automated Microbiology Market: Business Challenges, Emerging Technologies, Competitive Landscape

US$ 7,880.00

Complete report $9,850. DataPack (test volumes, sales forecasts, supplier shares) $6,400. New Frontiers in theU.S. Automated Microbiology Markets: Business Challenges, Emerging Technologies, Competitive Land scape is Venture Planning Group’s new analysis of the major business opportunities emerging in ...

May 2014 436 pages

New Frontiers in Coagulation Testing: Global Challenges, Emerging Technologies, Competitive Landscape

US$ 27,600.00

Complete report $34,500. DataPack (test volumes, sales forecasts, supplier shares) $21,100. Summary New Frontiers in Coagulation Testing: Global Challenges, Emerging Technologies, Competitive Landscape is Venture Planning Group’s new seven-country report designed to help current suppliers and ...

May 2014 650 pages

New Frontiers in the European Coagulation Testing Market: Business Challenges, Emerging Technologies, Competitive Landscape

US$ 15,760.00

Complete report $19,700. DataPack (test volumes, sales forecasts, supplier shares) $12,800. Summary New Frontiers in the European Coagulation Testing Market: Business Challenges, Emerging Technologies, Competitive Landscape is Venture Planning Group’s new five-country report designed to help ...

May 2014 500 pages

New Frontiers in the French Coagulation Testing Market: Business Challenges, Emerging Technologies, Competitive Landscape

US$ 4,880.00

... (test volumes, sales forecasts, supplier shares) $3,950. Summary New Frontiers in the French Coagulation Testing Market: Business Challenges, Emerging Technologies ... emerging business opportunities and develop effective strategies for the French coagulation testing market during the next five years. The ...

May 2014 405 pages

New Frontiers in the Italian Coagulation Testing Market: Business Challenges, Emerging Technologies, Competitive Landscape

US$ 4,880.00

Complete report $6,100. DataPack (test volumes, sales forecasts, supplier shares) $3,950. Summary New Frontiers in the Italian Coagulation Testing Market: Business Challenges, Emerging Technologies, Competitive Landscape is Venture Planning Group’s new report designed to help current suppliers and ...

May 2014 402 pages

New Frontiers in the Japanese Coagulation Testing Market: Business Challenges, Emerging Technologies, Competitive Landscape

US$ 5,920.00

Complete report $7,400. DataPack (test volumes, sales forecasts, supplier shares) $4,800. Summary New Frontiers in the Japanese Coagulation Testing Market: Business Challenges, Emerging Technologies, Competitive Landscape is Venture Planning Group’s new report designed to help current suppliers and ...

May 2014 402 pages

New Frontiers in the Spanish Coagulation Testing Market: Business Challenges, Emerging Technologies, Competitive Landscape

US$ 4,880.00

Complete report $6,100. DataPack (test volumes, sales forecasts, supplier shares) $3,950. Summary New Frontiers in the Spanish Coagulation Testing Market: Business Challenges, Emerging Technologies, Competitive Landscape is Venture Planning Group’s new report designed to help current suppliers and ...

May 2014 400 pages

New Frontiers in the UK Coagulation Testing Market: Business Challenges, Emerging Technologies, Competitive Landscape

US$ 4,880.00

Complete report $6,100. DataPack (test volumes, sales forecasts, supplier shares) $3,950. Summary New Frontiers in the UK Coagulation Testing Market: Business Challenges, Emerging Technologies, Competitive Landscape is Venture Planning Group’s new report designed to help current suppliers and ...

May 2014 409 pages

New Frontiers in the US Coagulation Testing Market: Business Challenges, Emerging Technologies, Competitive Landscape

US$ 7,680.00

Complete report $9,600. DataPack (test volumes, sales forecasts, supplier shares) $6,200. Summary New Frontiers in the U.S. Coagulation Testing Market: Business Challenges, Emerging Technologies, Competitive Landscape is Venture Planning Group’s new report designed to help current suppliers and ...

May 2014 424 pages

United States (USA)-Molecular Diagnostics Market, Test Volume Forecast & Companies

US$ 1,490.00

... Diseases a) Virology Testing b) HPV Testing c) HAI Testing d) Critical Care Testing 3. Genetic Testing 4. Blood Screening 5. Food Pathogen Testing 6. Tissue Typing ... 128 page report with 87 Figures studies the United States Molecular Diagnostics from 4 view points: 1) Market and Forecast 2) Application Wise ...

May 2014 128 pages

New Frontiers in the French Cancer Diagnostics Market: Business Challenges, Emerging Technologies, Competitive Landscape

US$ 5,360.00

... . DataPack (test volumes, sales forecasts, supplier shares) $4,350. New Frontiers in the French Cancer Diagnostics Market: Business Challenges, Emerging Technologies, ... during the nextfive years. The report examines trends in the French cancer diagnostics markets, reviews current and emerging assays; analyzes ...

May 2014 585 pages

New Frontiers in the German Cancer Diagnostics Market: Business Challenges, Emerging Technologies, Competitive Landscape

US$ 5,360.00

... . DataPack (test volumes, sales forecasts, supplier shares) $4,350. New Frontiers in the German Cancer Diagnostics Market: Business Challenges, Emerging Technologies, ... during the nextfive years. The report examines trends in the German cancer diagnostics markets, reviews current and emerging assays; analyzes ...

May 2014 585 pages

New Frontiers in the Italian Cancer Diagnostics Market: Business Challenges, Emerging Technologies, Competitive Landscape

US$ 5,360.00

Complete report $6,700. DataPack (test volumes, sales forecasts, supplier shares) $4,350. New Frontiers in the Italian Cancer Diagnostics Market: Business Challenges, Emerging Technologies, Competitive Landscape is Venture Planning Groups new study of the major business opportunities emerging in the Italian ...

May 2014 570 pages

New Frontiers in the Japanese Cancer Diagnostics Market: Business Challenges, Emerging Technologies, Competitive Landscape

US$ 7,040.00

Complete report $8,800. DataPack (test volumes, sales forecasts, supplier shares) $5,700. New Frontiers in the Japanese Cancer Diagnostics Market: Business Challenges, Emerging Technologies, Competitive Landscape is Venture Planning Groups new study of the major business opportunities emerging in the ...

May 2014 590 pages

New Frontiers in the Spanish Cancer Diagnostics Market: Business Challenges, Emerging Technologies, Competitive Landscape

US$ 5,360.00

Complete report $6,700. DataPack (test volumes, sales forecasts, supplier shares) $4,350. New Frontiers in the Spanish Cancer Diagnostics Market: Business Challenges, Emerging Technologies, Competitive Landscape is Venture Planning Groups new study of the major business opportunities emerging in the Spanish ...

May 2014 565 pages

New Frontiers in the UK Cancer Diagnostics Market: Business Challenges, Emerging Technologies, Competitive Landscape

US$ 5,360.00

Complete report $6,700. DataPack (test volumes, sales forecasts, supplier shares) $4,350. New Frontiers in the UK Cancer Diagnostics Market: Business Challenges, Emerging Technologies, Competitive Landscape is Venture Planning Groups new study of the major business opportunities emerging in the UK cancer ...

May 2014 565 pages

New Frontiers in the US Cancer Diagnostics Market: Business Challenges, Emerging Technologies, Competitive Landscape

US$ 7,840.00

Complete report $9,800. DataPack (test volumes, sales forecasts, supplier shares) $6,400. New Frontiers in the U.S. Cancer Diagnostics Market: Business Challenges, Emerging Technologies, Competitive Landscape is Venture Planning Groups new study of the major business opportunities emerging in the U.S. cancer ...

May 2014 620 pages

New Frontiers in Cancer Diagnostics: Global Challenges, Emerging Technologies, Competitive Landscape

US$ 27,600.00

... . DataPack (test volumes, sales forecasts, supplier shares) $21,100. New Frontiers in Cancer Diagnostics: Global Challenges, Emerging Technologies, Competitive Landscape is Venture ... specific antigens, and unlock the mystery of the genetic basis of the disease. During the next five years, the worldwide cancer ...

April 2014 1200 pages

New Frontiers in the European Cancer Diagnostics Market: Business Challenges, Emerging Technologies, Competitive Landscape

US$ 15,760.00

Complete report $19,700. DataPack (test volumes, sales forecasts, supplier shares) $12,800. New Frontiers in the European Cancer Diagnostics Market: Business Challenges, Emerging Technologies, Competitive Landscape is Venture Planning Groups new study of the major business opportunities emerging in the ...

April 2014 820 pages

India Genomics and Molecular Diagnostics Market Prospects to 2018 - Driven by Automation and Introduction of New Technologies

US$ 800.00

The report titled ‘India Genomics and Molecular Diagnostics Market Prospects to 2018 – Driven by Automation and Introduction of New Technologies’ presents a comprehensive ... screening test market Market size of India molecular HPV tests market Market size of India other molecular tests market (genetic testing ...

April 2014 68 pages

US Diabetes Monitoring, Treatment and Drug Delivery Market - 2014

US$ 6,995.00

... growing segments included the continuous glucose monitoring (CGM), insulin pump and supplies, modern insulin, insulin pens and pen needle markets. These segments have one aspect in common: they are newer ways of treating diabetes. CGM and pump technologies are improving at a fast pace toward full integration ...

April 2014 212 pages

Physician Views: Expanded access in cancer – how are oncologists utilising this opportunity?

US$ 695.00

... early access to a new cancer product, but a number of developers have also highlighted notable benefits derived from the process. To assess the view of expanded access programmes from the position of the physician community, FirstWord is polling oncologists based in the ...

April 2014

Incontinence in Kenya

US$ 990.00

Sales of incontinence remained insignificant in Kenya throughout the review period. This is partly due to limited retail ... , with adult incontinence remaining a taboo problem for consumers. Consumers suffering from incontinence thus rely on sanitary protection. Euromonitor International's Incontinence in Kenya report offers ...

April 2014 11 pages

Physician Views – Are oncologists ready to embrace real-world data?

US$ 695.00

... have their own particular views on how this resource can be used to improve the treatment of patients in the future? Are they aware of the ... physician perceptive towards real-world data, FirstWord polled 192 oncologists based in the US and EU5. Specifically we asked them How aware they are ...

April 2014

2014 Innovative Molecular and Immunohematology Blood Typing, Grouping and Infectious Disease NAT Technologies, and Their Market Applications

US$ 2,280.00

The report presents a comprehensive analysis of the clinical significance and market needs for major blood typing, grouping, and infectious disease screening assays, including NAT tests, as well as extensive listings of companies developing or marketing new blood banking technologies and products. Contains ...

April 2014 197 pages

2014 European Molecular Blood Typing, Grouping and Infectious Disease NAT Market: France, Germany, Italy, Spain, UK--Emerging Technologies, Sales Forecasts, Supplier Shares, Competitive Strategies

US$ 15,760.00

... market entrants identify and evaluate emerging opportunities in the European molecular blood banking market during the next five years, and ... , by test. Strategic Recommendations New product development opportunities for molecular blood typing, grouping and infectious disease NAT assays and instrumentation ...

April 2014 630 pages

2014 Italy Molecular Blood Typing, Grouping and Infectious Disease NAT Market: Emerging Technologies, Sales Forecasts, Supplier Shares, Competitive Strategies

US$ 4,880.00

... market entrants identify and evaluate emerging opportunities in the Italian molecular blood banking market during the next five years, and ... Laboratories Current and Emerging Products Analysis of current and emerging blood typing, grouping and Infectious Disease Screening Tests. Review of automated and ...

April 2014 430 pages

2014 Japan Molecular Blood Typing, Grouping and Infectious Disease NAT Market: Emerging Technologies, Sales Forecasts, Supplier Shares, Competitive Strategies

US$ 6,160.00

... market entrants identify and evaluate emerging opportunities in the Japanese molecular blood banking market during the next five years, and ... Laboratories Current and Emerging Products Analysis of current and emerging blood typing, grouping and Infectious Disease Screening Tests. Review of automated and ...

April 2014 430 pages

2014 UK Molecular Blood Typing, Grouping and Infectious Disease NAT Market: Emerging Technologies, Sales Forecasts, Supplier Shares, Competitive Strategies

US$ 4,880.00

... potential market entrants identify and evaluate emerging opportunities in the UK molecular blood banking market during the next five years, and ... Laboratories Current and Emerging Products Analysis of current and emerging blood typing, grouping and Infectious Disease Screening Tests. Review of automated ...

April 2014 430 pages

2014 US Molecular Blood Typing, Grouping and Infectious Disease NAT Market: Emerging Technologies, Sales Forecasts, Supplier Shares, Competitive Strategies

US$ 7,760.00

... and potential market entrants identify and evaluate emerging opportunities in the US molecular blood banking market during the next five years, and ... Blood Banks Current and Emerging Products Analysis of current and emerging blood typing, grouping and Infectious Disease Screening Tests. Review of automated ...

April 2014 465 pages

Hepatitis C: Game changing regimens to revolutionise treatment landscape - KOL Insight

US$ 7,495.00

... represents a paradigm shift compared to the protease inhibitors and interferon regimens. With convenient, efficacious and safer therapies coming through the ... will shape the future market. Key Benefits Therapy Trends: Hepatitis C -- Game changing regimens to revolutionise treatment landscape examines the most prominent insights gained ...

March 2014 163 pages

Cervical Cancer Test Market & Patients - Pap Smear, HPV DNA, VIA – Test & Patients – Worldwide

US$ 1,490.00

... are as follows 1. United Kingdom 2. France 3. Germany 4. Italy 5. Spain 6. Sweden 7. Switzerland 8. Norway 9. Netherlands 10. United States 11. Canada 12. Japan 13. Korea 14. Singapore 15. Malaysia 16. Australia 17. India 18. China 19. Thailand 20. Indonesia Data Sources This report is built using data ...

March 2014 232 pages

Global In-Vitro Diagnostics Market Forecast to 2018

US$ 1,700.00

... rising demand for POCT and technological advancements in the global market, the IVD market is going through a very exciting phase. Presently, the ... likely to witness strong growth in the coming years. In the latest research study, “Global In-Vitro Diagnostics Market Forecast to 2018”, RNCOS analysts identified ...

March 2014 145 pages

Europe In-Vitro Diagnostics Market Outlook to 2018 - Ageing Demographic and Mounting Consolidations to Drive Future Growth

US$ 1,200.00

The report titled “Europe In-Vitro Diagnostics Market Outlook to 2018 - Ageing Demographic and Mounting Consolidation to Drive Future Growth” provides a comprehensive ... Europe has showcased a gradual decline over the years. The market revenues have suffered owing to a gamut of factors. One of the major factors ...

March 2014 88 pages

Non-small cell lung cancer: Game changing immunotherapies to revolutionise treatment - KOL Insight

US$ 7,495.00

... KOL analysis of NSCLC treatments, development and competition, KOL Insight: Non-small cell lung cancer is an essential tool for keeping abreast of events that will shape ... Developments in the treatment of NSCLC are progressing rapidly. In KOL Insight: Non-small cell lung cancer, you will: Gain an invaluable overview into the most dynamic ...

March 2014 134 pages

Cancer Gene Therapy Market Analysis

US$ 1,800.00

... of Oncology Therapeutics in Gene Therapy Current Applications of Gene Therapy to Cancer Treatment Favorable Parameters for Cancer Gene Therapy Issued Involved with Application of Gene Therapy in Cancer Patients Regulatory Scenario for Gene Therapy Market Cancer Gene Therapy Drug Clinical ...

March 2014 300 pages

In-Vitro Diagnostics (IVD) Market Analysis and Segment Forecasts To 2020

US$ 4,450.00

... over the next six years. The professional diagnostic products dominated the overall IVD market in 2013, owing to the high ... global IVD market on the basis of product and region: IVD Market Product Outlook Molecular Diagnostics Tissue Diagnostics Diabetes Monitoring Professional Diagnostics IVD Market Regional ...

March 2014 78 pages

Competitive Intelligence 2014: World Blood Banking Market Key Players - Strategic Assessments of Major Suppliers and Emerging Market Entrants

US$ 1,960.00

This new report from Venture Planning Group provides strategic assessments of major blood banking product suppliers and emerging market entrants. The report presents analyses of major current and emerging suppliers in terms of their sales, market shares, product portfolios, marketing tactics, technological ...

February 2014 50 pages

Competitive Intelligence 2014: Leading Infectious Disease Market Players - Insightful Profiles of Major Suppliers and Emerging Market Entrants

US$ 1,960.00

... new report from Venture Planning Group provides strategic assessments of major suppliers of infectious deisease instuments and reagants, as well as emerging market entrants. The report presents strategic assessments of leading market players and emerging suppliers with innovative technologies and products in ...

February 2014 90 pages

Competitive Intelligence 2014: World Clinical Chemistry and Immunodiagnostics Market Key Players - Strategic Assessments of Major Suppliers and Emerging Market Entrants

US$ 1,960.00

... chemistry and immunodiagnostic product suppliers and emerging market entrants.The report presents strategic profiles of 25 current and emerging suppliers of clinical chemistry and immunodiagnostic products, including their sales, market shares, product portfolios, marketing tactics, technological know-how, ...

February 2014 42 pages

Competitive Intelligence 2014: Leading Hematology and Flow Cytometry Market Players - Strategic Assessments of Major Suppliers and Emerging Market Entrants

US$ 1,960.00

This new report from Venture Planning Group provides strategic assessments of major suppliers of hematology and flow cytometry instuments and reagants, as well as emerging market entrants. The report presents strategic analyses of the major current and emerging suppliers in terms of their sales, product ...

February 2014 30 pages

Competitive Intelligence 2014: Leading Microbiology Market Players - Insightful Profiles of Major Suppliers and Recent Market Entrants

US$ 1,960.00

This new 90-page report from Venture Planning Group provides insightful profiles of leading microbiology market players and recent market entrants. The report presents strategic assessments, including sales, product portfolios, distribution tactics, technological know-how, new products in R&D, collaborative ...

February 2014 90 pages

US Personalized Cancer Genome Sequencing Market Outlook 2018

US$ 1,200.00

... and the exponential decline in cost of whole genome sequencing. Our report entitled “US Personalized Cancer Genome Sequencing Market Outlook 2018” entails detailed ... in males and females. Further, we have provided potential states for whole genome sequencing to help market players gauge maximum opportunity for ...

February 2014 65 pages

Competitive Intelligence 2014: Analyses of Current and Emerging Suppliers of Immunodiagnositcs, Microbiology, Cancer Diagnostic, Molecular Diagnostic, Hematology, Coagulation and Blood Banking Instruments and Reagents

US$ 6,800.00

This new report from Venture Planning Group provides analyses of 100 major and emerging suppliers of immunodiagnositcs, microbiology, cancer diagnostic, molecular diagnostic, hematology, coagulation and blood banking instruments and reagents. The report presents strategic profiles of 100 major and emerging ...

February 2014

Competitive Intelligence 2014: Leading Flow Cytometry Market Players - Strategic Assessments of Major Suppliers and Emerging Market Entrants

US$ 1,960.00

This new report from Venture Planning Group provides strategic assessments of leading and emerging flow cytometry market players. The report presents strategic analyses of major current and emerging manufacturers of flow cytometry analyzers and consumables in terms of their sales, product portfolios, ...

February 2014 25 pages

Competitive Intelligence 2014: Leading Transfusion Diagnostic Testing Market Players - Strategic Assessments of Major Suppliers and Emerging Market Entrants

US$ 1,960.00

This new report from Venture Planning Group provides extensive analyses of major current and emerging suppliers of transfusion diagnostic instruments and reagents. The assessments include: Sales Product portfolios Marketing tactics Technological know-how New products in R&D Collaborative arrangements ...

February 2014 50 pages

Competitive Intelligence 2014: Leading Tumor Marker Diagnostics Market Players - Strategic Assessments of Major Suppliers and Emerging Market Entrants

US$ 2,000.00

This new 80-page report from Venture Planning Group provides insightful analyses of major current and emerging suppliers of tumor marker diagnostic instruments and reagents. The assessments include: Sales Product portfolios Distribution tactics Technological know-how New products in R&D Collaborative ...

February 2014 80 pages

Filters

Search

Categories

675
84
1,065
33,609
152
69
819
657
1,866
4,252
70

Publishers

1
8
9
36
1
15
4
40
1
1
17
12
4
1
1
13
2
1
53
1
1
9
9
328
1
2
1
5
16
1
1
13
4
40
1
2
8
5
16
19
36
7
10
6
2
3
174
108
13
53
3
29
15
1
4
7
18
3
24
3
32
1
15
2
7
2
81
45
11
78
1
14
2
22
3
74
41,216
1
40
2
17
15
24
85
6
10
51
11
62
48
1
45
23
49

Regions

280
15
1
134
138
137
137
136
136
135
134
131
130
175
38
16,410
447
192
191
191
137
4
3
2
198
197
196
196
196
195
194
194
194
192
106
193
195
193
192
107
195
138
203
194
189
200
198
196
139
105
195
194
194
193
195
176
198
197
138
112
197
197
195
195
193
193
138
138
136
135
135
1
1
200
198
197
195
194
198
197
196
195
195
195
194
194
194
195
195
191
138
138
137
108
16
1
1
198
1
108
1,215
1,213
1,197
1,192
1,172
245
2
263
194
195
203
197
1,227
1,153
1,668

Price

Date

Pages

Offers

34
6
1
15
84